In 2016, the FDA approved less than 50% of drugs submitted for approval the previous year, highlighting significant hurdles in pharmaceutical development. This white paper delves into the reasons behind this low approval rate, offering insights into the latest cost...
About this episode In today’s episode, guest-host Susanne Kerins discussed the topic of “Leading a Strategy Realization Office in Life Sciences” with Sachin Raje. Sachin is Director, Strategy Realization Office, MRL Global Medical and Scientific Affairs at Merck. He...
Having recently completed a tour of the life sciences conference circuit, both in the United States and Europe, several changing trends transforming Life Sciences became apparent. In this blog, we will take at some of the most outstanding project management trends...
In this presentation, Mario Clarizia of Elanco outlines how Cora PPM was used in establishing a portfolio management and prioritization program. Overview In growing organizations there comes a time when the number and value of projects means that it becomes difficult...
Overview This white paper explores some of the trends that are transforming project management in the life sciences sector, and in the pharmaceutical and medical devices industries. Including: The continued growth of agile Remote teams Attracting investors Integrating...
